Stock Earnings

Question 1

Quels sont les états financiers clés de Biodexa Pharmaceuticals PLC ?

Accepted Answer

Selon le dernier état financier (Form-10K), Biodexa Pharmaceuticals PLC a un total d'actifs de $14, un bénéfice net loss de $-5

Question 2

Quels sont les ratios financiers clés pour BDRX ?

Accepted Answer

Le ratio de liquidité de Biodexa Pharmaceuticals PLC est 2.33, la marge nette est 0, les ventes par action sont de $0.

Question 3

Comment les revenus de Biodexa Pharmaceuticals PLC sont-ils répartis par segment ou géographie ?

Accepted Answer

Biodexa Pharmaceuticals PLC largest revenue segment is Pipeline Research and Development, at a revenue of 473,602 in the most earnings release.For geography, Belgium is the primary market for Biodexa Pharmaceuticals PLC, at a revenue of 473,602.

Question 4

Biodexa Pharmaceuticals PLC est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Biodexa Pharmaceuticals PLC a un bénéfice net loss de $-5

Question 5

Biodexa Pharmaceuticals PLC a-t-elle des passifs ?

Accepted Answer

yes, Biodexa Pharmaceuticals PLC a un passif de 6

Question 6

Combien d'actions en circulation Biodexa Pharmaceuticals PLC a-t-elle ?

Accepted Answer

Biodexa Pharmaceuticals PLC a un total d'actions en circulation de 668.59

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	4	3	4	4	2	4
Research & Development	4	5	4	5	4	6
Operating Expenses	8	9	8	9	7	11
Other Non Operating Income (Expenses)	0	0	0	--	--	--
Pretax Income	-6	-5	-7	-8	-6	-23
Income Tax Expense	0	0	0	0	0	-1
Net Income	-6	-5	-7	-7	-5	-22
Net Income Growth	0%	-28.99%	0%	40%	-77%	120%
Shares Outstanding (Diluted)	2,526.72	495.27	31.58	0.49	0	0
Shares Change (YoY)	19,154%	1,468%	6,291%	247,000%	100%	0%
EPS (Diluted)	0	-0.01	-0.22	-15.49	-27,300	-201,718.18
EPS Growth	-99%	-95%	-99%	-100%	-86%	0%
Free Cash Flow	-11	-13	-7	-7	-6	-9
Free Cash Flow Per Share	0	-0.02	-0.22	-14.16	-30,000	-90,000
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-8	-9	-8	-8	-6	-9
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	1
EBIT	-8	-9	-8	-8	-6	-10
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	4.34%

Biodexa Pharmaceuticals PLC (BDRX) Price

BDRX Stock Price Chart

BDRX Income

Follow-Up Questions